BUY NTPC Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))26 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
NTPC Green Energy arm wins 500 MW capacity in SECI peak power tender at ₹6/kWh
NewsCnbc-Tv18·22 Aug · 3d ago
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·21 Aug · 4d ago
9 Sensex stocks with up to 41% upside potential. Are these in your portfolio?
NewsEt-Markets·16 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on NTPC
- SELL — Kunal Bothra23 Oct 2026 · ~2 weeks · target ₹280 · Active
- BUY — Sachin Gupta19 Oct 2026 · ~3 months · target ₹340 · Active
- BUY — Shrikant Chouhan, Kotak Securities16 Sept 2026 · ~3 months · target ₹355 · Active
- SELL — Laxmikant Shukla, YES Securities15 Sept 2026 · ~2 weeks · target ₹314 · Expired
- BUY — Bank of America14 Sept 2026 · ~1 year · target ₹432 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

